Inhalerx Limited (ASX:IRX)

7.8¢

right-arrow Created with Sketch. -0.01 (-11.36%)
MCAP $14.82M
Last trade 15.36pm 21/01/2022 20mins delayed

Latest Announcements

29/12/2021 Price SensitivePSIRXInhalerx Limited
21/12/2021IRXInhalerx Limited
03/12/2021IRXInhalerx Limited
01/12/2021IRXInhalerx Limited
01/11/2021 Price SensitivePSIRXInhalerx Limited
01/11/2021 Price SensitivePSIRXInhalerx Limited
29/10/2021IRXInhalerx Limited
26/10/2021IRXInhalerx Limited

Company Overview

Inhalerx Ltd, formerly Lifespot Health Ltd, is an Australia-based medical technology company. The Company is focused on developing inhaled therapies and medicine delivery systems. It offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. It utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.

IRX in the news

InhaleRx (IRX) sees its Chief Executive Officer, Matthew Golden, resign from the…

Search Previous Announcements